The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
达格列净预防慢性肾脏病不良结局(DAPA-CKD)试验:基线特征
期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfaa234
Wheeler, David C; Stefansson, Bergur V; Batiushin, Mikhail; Bilchenko, Oleksandr; Cherney, David Z I; Chertow, Glenn M; Douthat, Walter; Dwyer, Jamie P; Escudero, Elizabeth; Pecoits-Filho, Roberto; Furuland, Hans; Górriz, José Luis; Greene, Tom; Haller, Hermann; Hou, Fan Fan; Kang, Shin-Wook; Isidto, Rey; Khullar, Dinesh; Mark, Patrick B; McMurray, John J V; Kashihara, Naoki; Nowicki, Michal; Persson, Frederik; Correa-Rotter, Ricardo; Rossing, Peter; Toto, Robert D; Umanath, Kausik; Van Bui, Pham; Wittmann, István; Lindberg, Magnus; Sjöström, C David; Langkilde, Anna Maria; Heerspink, Hiddo J L